Tag: study
More than 60 animals confirmed with Sars-Cov-2 infection
Of the more than 60 animals confirmed with SARS-CoV-2 infection in a study of more than 450 animals living in the Brazos County area Texas A&M study, less than a quarter were reported to show signs of disease around the time of the owner’s diagnosis, most commonly including sneezing, coughing, diarrhea, or being less active than normal. More...
BMJ: B.1.1.7 “in addition to being more transmissible, seems to be more lethal”
Results The mortality hazard ratio associated with infection with VOC-202012/1 compared with infection with previously circulating variants was 1.64 (95% confidence interval 1.32 to 2.04) in patients who tested positive for Covid-19 in the community. More...
Antibody resistance of coronavirus variants B.1.351 (SA) and B.1.1.7 (UK)
“Findings on B.1.351 [South Africa variant] are more worrisome in that this variant is not only refractory to neutralization by most NTD mAbs but also by multiple individual mAbs to the receptor-binding motif on RBD, largely owing to an E484K mutation. More...
Coronavirus can sicken children in very different ways – both lung-related and PIMS MISC
About half the patients in the study had acute Covid-19, the predominantly lung-related illness that afflicts most adults who get sick. More...
Nearly half of all mild coronavirus cases have long-covid symptoms 6 months later
Almost half of all people with mild coronavirus cases still have at least one symptom six months after recovering, a new Israeli study found. More...
Quebec researchers say they have found an effective drug to fight COVID-19 – colchicine
A team of researchers from the Montreal Heart Institute believe they have found an effective weapon against COVID-19: Colchicine, an oral tablet already known and used for other diseases. More...
Long Covid Study: 6-month consequences of COVID-19 in patients discharged from hospital
The long-term health consequences of COVID-19 remain largely unclear. More...
Investigation of novel SARS-CoV-2 variant – Variant of Concern 202012/01
“Preliminary results from the cohort study found no statistically significant difference in hospitalisation and 28-day case fatality between cases with the variant (VOC-201212/01) and wild-type comparator cases. More...